Commonwealth Equity Services
MIRM icon

Commonwealth Equity Services’s Mirum Pharmaceuticals MIRM Stock Holding History

Commonwealth Equity Services’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Sell
2,230
-13,794
-86% -$1.38M ﹤0.01% 3887
2026
Q1 		$1.48M Sell
16,024
-67
-0.4% -$6.3K ﹤0.01% 2267
2025
Q4 		$1.27M Sell
16,091
-140
-0.9% -$10K ﹤0.01% 2384
2025
Q3 		$1.19M Buy
16,231
+472
+3% +$30K ﹤0.01% 2454
2025
Q2 		$802K Buy
15,759
+259
+2% +$11.5K ﹤0.01% 2758
2025
Q1 		$698K Buy
15,500
+1,450
+10% +$68.3K ﹤0.01% 2763
2024
Q4 		$581K Hold
14,050
– – ﹤0.01% 2843
2024
Q3 		$548K Hold
14,050
– – ﹤0.01% 2826
2024
Q2 		$480K Buy
14,050
+2,050
+17% +$53.7K ﹤0.01% 2866
2024
Q1 		$301K Hold
12,000
– – ﹤0.01% 3272
2023
Q4 		$354K Hold
12,000
– – ﹤0.01% 3020
2023
Q3 		$379K Buy
+12,000
New +$329K ﹤0.01% 2824

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Commonwealth Equity Services's MIRM Position: Q2 2026 in Review

Commonwealth Equity Services reduced its Mirum Pharmaceuticals (MIRM) stake by 86% in Q2 2026, selling an estimated $1.38M and leaving 2,230 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #3887.

Commonwealth Equity Services first reported a position in MIRM in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.48M in Q1 2026. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Commonwealth Equity Services held 2,230 shares of Mirum Pharmaceuticals worth $261K as of Q2 2026.
  • Commonwealth Equity Services sold 13,794 Mirum Pharmaceuticals shares in Q2 2026, an estimated $1.38M.
  • Mirum Pharmaceuticals made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q2 2026, its #3887 holding.
  • Commonwealth Equity Services first reported a position in Mirum Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Commonwealth Equity Services's Mirum Pharmaceuticals position peaked at $1.48M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Commonwealth Equity Services's 13F filing for Q2 2026, filed 29 Jul 2026.